Scanadu raises $35 million in Series B, develops for China market

[grow_thumb image=”http://telecareaware.com/wp-content/uploads/2015/04/Scanadu-Scout.jpg” thumb_width=”150″ /]Eric Topol’s Doctorless Patient takes one step closer to reality. The Scanadu ‘tricorder’ vital signs diagnostic ‘hockey puck’ received a major vote of confidence on Monday where it counts–funding. Their Series B of $35 million came from nine investors, led by Tencent Holdings, Fosun International and including Three Leaf Ventures, AME Cloud Ventures, Redmile Group, Relay Ventures, I Globe Partners, Fenox Venture Capital and CBC Capital. Three Leaf, AME and Relay also invested in their Series A. Tencent, Fosun and CBC are Chinese; I Globe is from Singapore. Why the Asian interest? It turns out that China is extremely interested and forward thinking in mobile healthcare–it has a lot of rural area to cover, all health-underserved, as is the rest of Asia. The introduction of the company was made by Jerry Wang, a Yahoo founder and former CEO.

Scanadu is also nearing market: Fortune reports that a $199 consumer version of the Scanadu Scout will be released in 2016, pending FDA approval, and in development is a urinalysis test, Scanadu Urine, an app that would analyze the color of a testing stick. (more…)

34 to 22 to 10: the Tricorder XPrize finalists

The Qualcomm Tricorder XPrize has arrived at the ‘Final 10’ for the $10 million prize going to the best (and working) “precision diagnostic technolog(y), making definitive health assessment available directly to “health consumers.”” . Less than one year ago, 34 companies had made it through from the initial 255 [TTA 12 Nov 13]. Further reductions brought the next stage to 22. Making the Final 10 are, as expected, Scanadu, but the UK/NI favorite has to be zensor (Intelesens) with its sensor-based patient monitoring in home, hospitals and assisted living (which your Editors have been following since 2010). Four are American companies with one Canadian (Cloud DX), one Indian (Danvantri), one Taiwanese (Dynamical Biomarkers Group), tw0 from the UK (zensor and SCANurse) and one from Slovenia (MESI). Next steps? Supplying X Prize with working prototypes sometime this wenter, 30 complete devices which will be tested at a medical center (not disclosed) May-October 2015 and the award in January 2016. Press release, Mobihealthnews.

Not X enough for you? There’s another, little-noticed XPrize–the Nokia Sensing XChallenge (more…)